Capital Flow Monitor · Sponsors · CIK 1807983
Medicenna Therapeutics Corp.
2 BLOOR STREET W, TORONTO, A6, M4W 3E2 · 604-671-6673
Biotechnology · Corporation· inc. CANADA (FEDERAL LEVEL) true
Fit score
—
Offering
$2.3M
Sold
$253K
% sold
10.8%
Investors
3
Min investment
$0
Exemption
506(b)
Filing history
| Filed | Form | Rule | Offering | Sold | % sold | Investors | |
|---|---|---|---|---|---|---|---|
| 2026-07-06 | D ·current | 506(b) | $2.3M | $253K | 10.8% | 3 | EDGAR ↗ |
Related persons
Executive officers, directors and promoters, as filed. Other raises are matched by exact name and show amount sold as last reported.
- Fahar Merchant — Executive Officer / Director, Toronto, A6
-
David Hyman — Executive Officer, Toronto, A6
2 other raises
- Attivo Omaha Investors LLC $100K of $16.0M · 0.6%
- Prairie Pointe Investors, L.C. $4.0M of $12.0M · 33.1%
- Nageatte Ibrahim — Executive Officer, Toronto, A6
- Rosemina Merchant — Executive Officer, Toronto, A6
- Albert G. Beraldo — Director, Toronto, A6
- John Geltosky — Director, Toronto, A6
- Karim Lalji — Director, Toronto, A6
- Richard Sutin — Director, Toronto, A6
- Angelos Georgakis — Director, Toronto, A6
Placement agents
- No sales compensation reported — direct raise.
Source: SEC EDGAR Form D. Self-reported by the issuer. Not investment advice.